Triple-responsive catechin-engineered hyaluronic acid micelles for intracellular delivery of doxorubicin.
The potential of PEG-HA-EGCG micelles as a polysaccharide-based nanoplatform integrating high-capacity drug loading, tumor-responsive release, and targeted intracellular delivery for cancer therapy is demonstrated.